CIBC Asset Management’s 10x Genomics TXG Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-15,938
| Closed | -$360K | – | 1296 |
|
|
2024
Q3 | $360K | Sell |
15,938
-79,321
| -83% | -$1.79M | ﹤0.01% | 818 |
|
|
2024
Q2 | $1.85M | Buy |
95,259
+23,112
| +32% | +$450K | 0.01% | 563 |
|
|
2024
Q1 | $2.71M | Buy |
+72,147
| New | +$2.71M | 0.01% | 502 |
|
|
2023
Q2 | – | Sell |
-160,750
| Closed | -$8.97M | – | 1115 |
|
|
2023
Q1 | $8.97M | Sell |
160,750
-128,394
| -44% | -$7.16M | 0.04% | 259 |
|
|
2022
Q4 | $10.5M | Sell |
289,144
-46,262
| -14% | -$1.69M | 0.04% | 223 |
|
|
2022
Q3 | $9.55M | Buy |
+335,406
| New | +$9.55M | 0.04% | 224 |
|
|
2022
Q2 | – | Sell |
-4,530
| Closed | -$345K | – | 1472 |
|
|
2022
Q1 | $345K | Hold |
4,530
| – | – | ﹤0.01% | 975 |
|
|
2021
Q4 | $675K | Buy |
4,530
+114
| +3% | +$17K | ﹤0.01% | 776 |
|
|
2021
Q3 | $643K | Buy |
4,416
+441
| +11% | +$64.2K | ﹤0.01% | 770 |
|
|
2021
Q2 | $778K | Hold |
3,975
| – | – | ﹤0.01% | 730 |
|
|
2021
Q1 | $719K | Buy |
3,975
+463
| +13% | +$83.7K | ﹤0.01% | 724 |
|
|
2020
Q4 | $497K | Hold |
3,512
| – | – | ﹤0.01% | 751 |
|
|
2020
Q3 | $438K | Buy |
3,512
+87
| +3% | +$10.9K | ﹤0.01% | 730 |
|
|
2020
Q2 | $306K | Hold |
3,425
| – | – | ﹤0.01% | 793 |
|
|
2020
Q1 | $213K | Hold |
3,425
| – | – | ﹤0.01% | 848 |
|
|
2019
Q4 | $261K | Buy |
+3,425
| New | +$261K | ﹤0.01% | 930 |
|